Gill, M.
3 papers on CoChat
Most cited papers
- Verified
Screening for glucose perturbations and risk factor management in dysglycemic patients with coronary artery disease—a persistent challenge in need of substantial improvement: a report from ESC EORP EUROASPIRE V
Ferrannini, G., De Bacquer, D., De Backer, G., Kotseva, K., Mellbin, L., Wood, D., Rydén, L., collaborators, E. V., Gale, C. P., Beleslin, B., et al. (2020) · Diabetes Care
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management
Cited by 75
- Verified
Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data
Sierra, J. A., Shah, M., Gill, M. S., Flores, Z., Chawla, H., Kaufman, F. R., & Vigersky, R. (2018) · Journal of Medical Economics
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 38
- Verified
C-peptide and beta-cell autoantibody testing prior to initiating continuous subcutaneous insulin infusion pump therapy did not improve utilization or medical costs among older adults with diabetes mellitus
Gill, M., Chhabra, H., Shah, M., Zhu, C., & Grunberger, G. (2018) · Endocrine Practice
Diabetes Management and ResearchDiabetes Treatment and Management
Cited by 8
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free